Literature DB >> 11603648

Antiinflammatory activities of lactoferrin.

O M Conneely1.   

Abstract

Lactoferrin is a non-heme iron binding glycoprotein produced during lactation and by epithelial cells at mucosal surfaces. The protein is a prominent component of the first line of mammalian host defense and its expression is upregulated in response to inflammatory stimuli. In this paper, the antibacterial and immune modulatory properties of lactoferrin that contribute to host defense are reviewed. In addition, the results of recent preclinical and clinical studies demonstrating that lactoferrin acts as an inhibitor of dermal inflammatory cytokine production are summarized. The results indicate that lactoferrin may act as a potent anti-inflammatory protein at local sites of inflammation including the respiratory and gastrointestinal tracts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11603648     DOI: 10.1080/07315724.2001.10719173

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  30 in total

1.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

2.  Altered gene expression profile in vaginal polypoid endometriosis resembles peritoneal endometriosis and is consistent with increased local estrogen production.

Authors:  S M Syrcle; K E Pelch; A L Schroder; B M Nichols; M P Mills; B F Barrier; A D Havey; S C Nagel
Journal:  Gynecol Obstet Invest       Date:  2010-12-09       Impact factor: 2.031

3.  Killing of Cryptosporidium sporozoites by Lactoferrin.

Authors:  Jose Luis Paredes; Hayley Sparks; A Clinton White; Griselle Martinez-Traverso; Theresa Ochoa; Alejandro Castellanos-González
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

4.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Intrauterine programming of fetal islet gene expression in rats--effects of maternal protein restriction during gestation revealed by proteome analysis.

Authors:  T Sparre; B Reusens; H Cherif; M R Larsen; P Roepstorff; S J Fey; P Mose Larsen; C Remacle; J Nerup
Journal:  Diabetologia       Date:  2003-09-12       Impact factor: 10.122

6.  Expression and localization of lactotransferrin messenger RNA in the cortex of Alzheimer's disease.

Authors:  Li An; Haruhisha Sato; Yoshihiro Konishi; Douglas G Walker; Thomas G Beach; Joseph Rogers; Ikuo Tooyama
Journal:  Neurosci Lett       Date:  2009-02-04       Impact factor: 3.046

7.  Oral administration of bovine whey proteins to mice elicits opposing immunoregulatory responses and is adjuvant dependent.

Authors:  A O Afuwape; M W Turner; S Strobel
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

8.  Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model.

Authors:  Marian L Kruzel; Jeffrey K Actor; Zsolt Radak; Attila Bacsi; Alfredo Saavedra-Molina; Istvan Boldogh
Journal:  Innate Immun       Date:  2009-09-01       Impact factor: 2.680

9.  Dietary lactoferrin alleviates age-related lacrimal gland dysfunction in mice.

Authors:  Motoko Kawashima; Tetsuya Kawakita; Takaaki Inaba; Naoko Okada; Masataka Ito; Shigeto Shimmura; Mitsuhiro Watanabe; Ken Shinmura; Kazuo Tsubota
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

10.  Effects of orally administered lactoferrin and lactoperoxidase-containing tablets on clinical and bacteriological profiles in chronic periodontitis patients.

Authors:  Eiju Shimizu; Tetsuo Kobayashi; Hiroyuki Wakabayashi; Koji Yamauchi; Keiji Iwatsuki; Hiromasa Yoshie
Journal:  Int J Dent       Date:  2011-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.